Endocardial biventricular pacing for chronic heart failure patients: Effect on transmural dispersion of

Muhammad Yamin1, Yoga Yuniadi2, Idrus Alwi1

  • 1Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital Jakarta Indonesia.

Journal of Arrhythmia
|August 15, 2019
PubMed

Insights

Endocardial biventricular pacing can reduce fatal arrhythmia by decreasing transmural dispersion of repolarization (TDR). Pacing at the right ventricular apex and left ventricular lateral/posterolateral walls achieved the most homogenous TDR, suggesting improved safety for cardiac resynchronization therapy.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Conventional epicardial cardiac resynchronization therapy (CRT) is linked to fatal arrhythmias due to increased transmural dispersion of repolarization (TDR).
  • The impact of endocardial biventricular pacing locations on TDR and subsequent arrhythmia risk remains unclear.

Purpose of the Study:

  • To determine the optimal endocardial biventricular pacing location for minimizing TDR.
  • To identify pacing strategies that reduce the risk of fatal arrhythmias in chronic heart failure (CHF) patients.

Main Methods:

  • A before-and-after study design was employed in adult CHF patients undergoing endocardial biventricular pacing.
  • Transmural dispersion of repolarization (TDR) was measured and compared across various pacing locations.
  • Statistical analysis assessed the homogeneity of TDR at different pacing sites.

Main Results:

  • The highest TDR was observed with right ventricular outlet septum and left ventricular lateral wall pacing (RVOTseptum-LVlateral).
  • The lowest TDR was achieved with right ventricular apex and left ventricular posterolateral wall pacing (RVapex-LVposterolateral).
  • Pacing at the right ventricular apex combined with the left ventricular lateral or posterolateral walls demonstrated the most homogenous TDR.

Conclusions:

  • Endocardial biventricular pacing at the right ventricular apex and left ventricular lateral/posterolateral walls effectively homogenizes TDR.
  • These pacing locations hold promise for reducing fatal arrhythmias associated with CRT in heart failure patients.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
768
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
720
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
821
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
225